Document Type : Original Article


1 Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

2 Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

3 Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

4 Department of Cardiology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

5 Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Science, Isfahan, Iran



INTRODUCTION: In recent years, transradial cardiac catheterization has become the preferred method. However, it can result in a significant complication known as radial artery occlusion (RAO). The medical management of RAO remains controversial, especially with the emergence of novel oral anticoagulants. Nevertheless, there is limited data on the use of these agents for treating RAO, which is the focus of this study using apixaban.
METHOD: This pilot double-blinded randomized clinical trial involved 30 patients who developed RAO following transradial coronary angiography. The patients were randomly assigned to receive either apixaban (2.5 mg twice daily) or a conservative approach for 30 days. Doppler ultrasonography was performed at baseline and at the end of the intervention to assess radial artery diameter and the resolution of arterial patency. Demographic, medical, medication, and clinical characteristics were collected.
RESULTS: The mean age of the studied population was 59.43±12.14 years, and the majority were males (60%). Radial artery resolution was observed in 21 (70%) patients, independent of medication use. There was no significant association between resolution and age (P-value=0.62), gender (P-value=0.74), body mass index (P-value=0.23), smoking (P-value=0.64), diabetes (P-value=0.999), hypertension (P-value=0.74), statins (P-value=0.999), antiplatelet therapy (P-value=0.999), length of angiography (P-value=0.216), or follow-up arterial diameter (P-value=0.304). Recanalization occurred in 13 (86.7%) cases in the apixaban treatment group, compared to 8 (53.3%) individuals in the control group, indicating a significant difference (P-value=0.046).
CONCLUSION: The study findings suggest no demographic, medical, medication, or clinical factors were associated with arterial recanalization. However, a one-month treatment with apixaban at a dose of 2.5 mg twice daily appeared to be effective.


1. Campeau L. Percutaneous radial artery approach for coronary angiography. Catheter Cardiovasc Diagn 1989; 16(1): 3-7.
2. Kiemeneij F, Laarman GJ, de Melker E. Transradial artery coronary angioplasty. Am Heart J 1995; 129(1): 1-7.
3. Kiemeneij F, Laarman GJ, Odekerken D, Slagboom T, van der Wieken R. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the access study. J Am Coll Cardiol 1997; 29(6): 1269-75.
4. Di Santo P, Simard T, Wells GA, Jung RG, Ramirez FD, Boland P, et al. Transradial versus transfemoral access for percutaneous coronary intervention in ST-segment-elevation myocardial infarction: a systematic review and meta-analysis. Circ Cardiovasc Interv 2021; 14(3): e009994.
5. Steinmetz M, Radecke T, Boss T, Stumpf MJ, Lortz J, Nickenig G, et al. Radial artery occlusion after cardiac catheterization and impact of medical treatment. Vasa. 2020.
6. Bolorunduro O, Bob-Manuel T, Cheema Y, Raza A, Khouzam R. Gaining a new skill with the risk of losing one: the effect of radial catheterization. Curr Probl Cardiol 2016; 41(5): 195-203.
7. Nguyen P, Makris A, Hennessy A, Jayanti S, Wang A, Park K, et al. Standard versus ultrasound-guided radial and femoral access in coronary angiography and intervention (SURF): a randomised controlled trial. EuroIntervention 2019; 15(6): e522-e30.
8. Wagener JF, Rao SV. Radial artery occlusion after transradial approach to cardiac catheterization. Curr Atheroscler Rep 2015; 17: 1-8.
9. Goswami R, Oliphant CS, Youssef H, Morsy M, Khouzam RN. Radial artery occlusion after cardiac catheterization: significance, risk factors, and ‎management. Curr Probl Cardiol 2016; 41(6): 214-27.
10. Lavi S, Cheema A, Yadegari A, Israeli Z, Levi Y, Wall S, et al. Randomized trial of compression duration after transradial cardiac catheterization and intervention. J Am Heart Assoc 2017; 6(2): e005029.
11. Uhlemann M, Gielen S, Woitek FJ, Moebius-Winkler S, Linke A, Schuler GC, editors. Impact of low molecular weight heparin on reperfusion rates in patients with radial artery occlusion after cardiac catheterization. Results and follow-up in 113 patients. J Am Coll Cardiol 2011.
12. Zankl A, Andrassy M, Volz C, Ivandic B, Krumsdorf U, Katus H, et al. Radial artery thrombosis following transradial coronary angiography: incidence and rationale for treatment of symptomatic patients with low-molecular-weight heparins. Clin Res Cardiol 2010; 99: 841-7.
13. Didagelos M, Pagiantza A, Zegkos T, Papanastasiou C, Zarra K, Angelopoulos V, et al. Low-molecular-weight heparin in radial artery occlusion treatment: the LOW-RAO randomized study. Future Cardiol 2021; 18(2): 91-100.
14. Dharma S, Kedev S, Patel T, Kiemeneij F, Gilchrist IC. A novel approach to reduce radial artery occlusion after transradial catheterization: postprocedural/prehemostasis intra‐arterial nitroglycerin. Catheter Cardiovasc Interv 2015; 85(5): 818-25.
15. Chen Y, Ke Z, Xiao J, Lin M, Huang X, Yan C, et al. Subcutaneous injection of ‎nitroglycerin at the radial artery puncture site reduces the risk of early radial artery occlusion after transradial coronary catheterization: a randomized, placebo-controlled clinical trial. Circ Cardiovasc Interv 2018; 11(7): e006571.
16. Beyranvand M, Mohammadi Z, Piranfar MA, Gachkar L. Effects of Verapamil on the Reduction of Radial Artery Thrombosis after Coronary Angiography: A Randomized Clinical Trial. J Tehran Univ Heart Cent 2022; 17(4): 180-5.
17. Dwivedi SK, Sharma AK, Nayak GR, Chaudhary GK, Chandra S, Pradhan A, et al. Factors influencing radial artery occlusion after transradial coronary intervention in the Indian population. Anatol J Cardiol 2022; 26(2): 105.
18. Rammos C, Burghardt A, Lortz J, Azizy O, Jánosi R, Steinmetz M, et al. Impact of anticoagulation and vasoactive medication on regained radial artery patency after catheterization: a case-control study. Eur J Med Res 2018; 23: 1-6.
19. Roy S, Choxi R, Wasilewski M, Jovin IS. Novel oral anticoagulants in the treatment of radial artery occlusion. Catheter Cardiovasc Interv 2021; 98(6): 1133-7.
20. Liang D, Lin Q, Zhu Q, Zhou X, Fang Y, Wang L, et al. Short-term postoperative use of rivaroxaban to prevent radial artery occlusion after transradial coronary procedure: the RESTORE randomized trial. Circ Cardiovasc Interv 2022; 15(4): e011555.
21. Schlosser J, Herrmann L, Böhme T, Bürgelin K, Löffelhardt N, Nührenberg T, et al. Incidence and predictors of radial artery occlusion following transradial coronary angiography: the proRadial trial. Clin Res Cardiol 2022: 1-11.
22. Sinha SK, Jha MJ, Mishra V, Thakur R, Goel A, Kumar A, et al. Radial artery ‎occlusion-incidence, predictors and long-term outcome after transradial ‎catheterization: clinico-Doppler ultrasound-based study (RAIL-TRAC study). Acta Cardiol 2017; 72(3): 318-27.
23. Garg N, Madan B, Khanna R, Sinha A, Kapoor A, Tewari S, et al. Incidence and predictors of radial artery occlusion after transradial coronary angioplasty: Doppler-guided follow-up study. J Invasive Cardiol 2015; 27(2).
24. Buturak A, Gorgulu S, Norgaz T, Voyvoda N, Sahingoz Y, Degirmencioglu A, et al. The long-term incidence and predictors of radial artery occlusion following a transradial coronary procedure. Cardiol J 2014; 21(4): 350-6.